Blue Trust’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10
Closed -$249 – 2544
2026
Q2
$249 Sell
10
-41
-80% -$960 ﹤0.01% 2385
2026
Q1
$715 Hold
51
– – ﹤0.01% 2302
2025
Q4
$573 Sell
51
-7
-12% -$80 ﹤0.01% 2370
2025
Q3
$670 Buy
58
+38
+190% +$445 ﹤0.01% 2380
2025
Q2
$245 Buy
20
+10
+100% +$126 ﹤0.01% 2371
2025
Q1
$143 Hold
10
– – ﹤0.01% 2436
2024
Q4
$159 Buy
+10
New +$198 ﹤0.01% 2390
2024
Q1
– Sell
-53
Closed -$1K – 2196
2023
Q4
$1K Buy
+53
New +$1.09K ﹤0.01% 2260
2023
Q1
– Sell
-4
Closed – – 2299
2022
Q4
$0 Hold
4
– – ﹤0.01% 2226
2022
Q3
$0 Buy
+4
New +$105 ﹤0.01% 2078

Other funds holding AVNS

Blue Trust's AVNS Position: Q3 2026 in Review

Blue Trust sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 10 shares — an estimated $249 sold.

Blue Trust first reported a position in AVNS in Q3 2022 and held it in 10 quarters. The position peaked at $1K in Q4 2023. 2 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.

  • Blue Trust reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
  • Blue Trust sold 10 Avanos Medical shares in Q3 2026, an estimated $249.
  • Blue Trust first reported a position in Avanos Medical in Q3 2022 and held it in 10 quarters.
  • Blue Trust's Avanos Medical position peaked at $1K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.